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Abstract
Objective: Novel approaches to nonsurgical permanent contraception (NSPC) for women
that are low cost and require no incision or hysteroscope/surgical equipment could
improve access to, and the acceptability of permanent contraception (PC). To better
understand opportunities and limitations for NSPC approaches, we examined women's
and OB/GYN providers' perceptions of NSPC in Portland, OR.
Study Design: Semi-structured, qualitative interviews were conducted with 40 women
recruited from outpatient clinics with purposive sampling, and a focus group was
conducted with 9 OB/GYNs in academic and community practice. Transcripts were
coded and inductively analyzed with a grounded theory approach.
Results: The majority of women identified as white (67%) or Latina (25%). They had a
median age of 31.5, and median number of children was one. Perspectives on NSPC were
closely aligned with women's general attitudes towards PC; over half were considering
PC for themselves or partners in the future. Most respondents valued multiple aspects of
a nonsurgical approach, with themes of minimizing recovery time, invasiveness, risk, and
avoiding hormonal contraception. Many assumed NSPC would be less effective than
surgery, however, and felt a confirmation test would be necessary regardless of the
failure rate. Providers welcomed efforts to expand contraceptive choice with NSPC, but
would require long-term safety and efficacy data before recommending, and voiced
concerns that NSPC's potential relative ease of administration could undermine the
inherent seriousness of choosing PC.
Conclusions: Women’s and providers’ perceptions of NSPC hinged on the ways in which
they conceptualized risk and effectiveness. While perceptions were generally favorable,
confirmation of safety and effectiveness would be required for a new approach to be
accepted.
Implications: This hypothesis-generating study elucidates women’s and provider’s
perspectives on new methods of NSPC, and contributes to understanding their
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perceptions of various types of risk. A technique to verify tubal occlusion would be
needed for women and providers to accept NSPC.

Keywords
Sterilization, permanent contraception, contraceptive development, risk, perception,
qualitative

Word count
3563 (Introduction 602, Methods 521, Results 1416, Discussion 1024); Abstract 300
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1. Introduction
The global need for highly effective contraceptive methods far outstrips access to
and utilization of these methods [1,2]. Although the continued development of femalecontrolled barrier methods and long-acting reversible contraception has expanded
contraceptive choice and access, surgical female sterilization, or permanent contraception
(PC), remains the most highly-utilized and effective method in the global setting. Over
one-third of reproductive age women worldwide reply upon female PC [1,3]. In the
United States, surgical female PC is the most commonly used method of contraception
among parous women, and the most prevalent method among women aged 30 or older
[4].
While female PC is highly prevalent, it is also the only method of contraception
for women that requires a surgical procedure—whether that procedure is hysteroscopic,
laparoscopic, or via laparotomy [5]. For some women, surgery may not be palatable or
advisable. While surgical complications are very low in the U.S. [6], surgical risk exists.
Globally, patient safety data for surgical sterilization are lacking, though catastrophic
complications periodically surface in the media [7]. Cost to the medical system and
insurance coverage also complicate access to surgical sterilization. Some women face
barriers in accessing PC, which contributes to the risk of unintended pregnancy [8-11].
Widespread interest in a simple, safe, nonsurgical approach to PC led to the
promotion of quinacrine in many developing countries in the 1980s and 90s [12-14].
Concerns about toxicities and efficacy, as well as the politicization of the method, have
all limited long-term prospects for this method [15,16]. The Essure® micro-insert system
for female sterilization is marketed as nonsurgical [17], and has expanded women’s
options for PC where it is offered. However, this procedure requires the use of a
hysteroscope, a surgical endoscope that requires a trained surgeon, and placement of
permanent coil inserts. While there are no incisions, this approach remains too resource
intensive for many settings. For the purposes of this paper, hysteroscopic sterilization is
not considered a new method of nonsurgical permanent contraception (NSPC).
New, nonsurgical PC methods are currently in development. One such method,
polidocanol, is a prototype agent for NSPC designed to be administered transcervically as
a foam via a small balloon catheter. Polidocanol is a sclerosing agent that has been used
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for years as a treatment for varicose veins [18]. In preclinical trials in non-human
primates, this agent has shown promise as a safe and effective PC method [19,20].
The development of a new contraceptive method that is acceptable and appealing
to women requires insight into potential user perspectives. Contraceptive users’ responses
to their options can be characterized as a “complex interplay between a woman, a
technology, and a service delivery environment” [21]. While there is some historical data
on the user acceptability of NSPC, it is limited to studies of quinacrine in low resource
settings [14,22]. There exist no data on perceptions of NSPC in the U.S. or Europe.
Traditional acceptability studies have been criticized for not taking into account the
broader context of women’s lives, including their levels of reproductive autonomy.
Women often cannot accurately predict their preferences about specific hypothetical
methods in isolation from other factors [21]. Given that an NSPC method is not yet
available, we designed a study to qualitatively explore women’s, men’s, and women’s
healthcare providers’ perspectives on NSPC. We focused on gaining nuanced perceptions
of PC, surgery, and responses to new methods, rather than on whether a specific method
would be “acceptable” to a particular population. We aimed to inform the contraceptive
development process, and generate hypotheses for future research on NSPC. In this
paper, we examine perceptions of NSPC among women and women’s healthcare
providers in Portland, OR.

2. Methods
This mixed-methods study incorporates qualitative interviews with
married/partnered women, a focus group with obstetrician-gynecologists (OB/GYNs),
and a survey with men. The study, conducted in Portland, OR from July-October 2013,
was approved by the institutional review board at Oregon Health & Science University
(OHSU). Findings from the male survey are presented elsewhere, as are findings from a
parallel study conducted in eastern Maharashtra, India in early 2014.

2.1 Semi-structured interviews
Semi-structured interviews were conducted with 40 married/partnered women.
Inclusion criteria were age 18-45, in a relationship with a man and theoretically “at risk
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for pregnancy” (has not undergone female PC/hysterectomy), pregnant or having at least
1 child, and English or Spanish-speaking. Women were recruited in person from two
outpatient women’s health and primary care clinics: the OHSU Center for Women’s
Health in Portland, OR, and the Virginia Garcia Memorial Health Center in Hillsboro,
OR. Interviews were conducted in English or Spanish. Participants were identified via a
combination of purposive/quota and convenience sampling. Quotas included at least 10
women identifying as Latina, and no more than 50% pregnant participants. The sample
size was determined based on the number expected to allow for theoretical saturation, or
the point at which no new conceptual insights are generated [23]. Two experienced
female study staff members who were trained in qualitative methods, and one of whom
was bilingual in English and Spanish, conducted all interviews. Demographic information
was collected via closed-ended questions at the outset of the interview. Interview themes
included contraceptive decision-making, perceptions of permanent contraception and
surgery, and responses to new contraceptive methods including NSPC; see figure 1 for
representative content. Participants received a $50 gift card upon completion of the
interview.

2.2 Focus group discussion (FGD)
A single FGD was conducted with nine OB/GYNs practicing in the Portland area.
Participants were recruited by email and represented both community and academic
generalist practice. An introductory script with a general description of polidocanol was
read to participants, and is included in figure 1. Two authors facilitated the FGD and did
answer basic questions about polidocanol, though placed emphasis on the concept of
NSPC rather than the specific method. The FGD focused on providers’ perspectives on
surgical sterilization, and new contraceptive technologies in development, such as NSPC.
The FGD was audio-recorded and transcribed.

2.3 Data analysis
Interviews and the FGD were audio-recorded, transcribed, and where applicable,
translated into English. Interview transcripts were analyzed with an inductive approach
using principles of grounded theory [23,24]. After reading all raw transcripts,
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investigators reached consensus on initial codes and created a working code book. After
twenty transcripts were independently coded in NVivo (QSR International Version 10,
2012), two investigators compared their coding line-by-line, added additional codes when
necessary, and resolved coding discrepancies prior to resuming the coding process.
NVivo was used to group codes and categories during the axial coding process and
memo-writing. The research team then met to further refine the categories and concepts
that emerged from the memos, reaching theoretical saturation on the concepts of interest.
The FGD transcript was manually coded, and content was analyzed for themes and
variant views. Informal member checking was subsequently performed.

3. Results
3.1 Semi-structured interviews
Interview participants had a median age of 32, with a range of 23-42. The
majority identified as white (67%) or Latina (25%). 70% were married, and had a median
of 1 child. Of the 40 participants, half were pregnant, and half had a college or graduate
degree. See Table 1 for participant characteristics.

3.1.1 Attitudes towards permanent contraception:
Most of the interview participants (23 out of 40) were considering or planning
future use of PC. Of these, 10 were considering vasectomy, 9 were considering tubal
sterilization, and 4 were considering either/both. All but a few respondents expressed
support for PC as a personal choice when asked “What do you think about permanent
contraception?” Yet, most placed conditions on when PC is appropriate, such as age,
relationship status, level of certainty and number of children a woman already has:
“If the woman makes it with the understanding that it's permanent...and she's at
the proper age where she can, like, 20 might be a little too young for that
choice…”

Most women (75%) supported PC in the immediate post-partum period; those who did
not were concerned about compromised decision-making, regret, and the stress of
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surgery. Finally, 20% (8/40) of women expressed the view that their male partners should
“take his turn” in contraceptive responsibility by undergoing vasectomy.

3.1.2 Interest in NSPC
Perceptions of NSPC were closely aligned with women's general attitudes
towards PC. Most respondents expressed interest in multiple aspects of a nonsurgical
approach. In particular, most assumed it would be less invasive than surgery and that
NSPC would likely avoid risks associated with anesthesia.
“Uh, just that it’s not surgical. Any surgery has a risk, basically, for
infections…or anesthesia is a serious thing, so that’s pretty much the appeal. I
know everything has risk, but, maybe less of a risk.”

Several women also mentioned reduced recovery time with a nonsurgical procedure as a
major advantage; they anticipated that a less invasive procedure would allow for less
missed work, less pain, and less “down time” as parents.
“Well, the recovery time…I mean if it’s nonsurgical I’m assuming there’s not that
big of a recovery period. So, to me that would be very appealing….”

Others brought up various benefits of NSPC, including the likelihood of reduced cost, an
outpatient venue, avoiding hormonal contraception due to perceived side effects, and
increased accessibility at a public health level. Regarding the latter, one participant
hypothesized that a simpler, nonsurgical method would be cheaper and require less input
from the healthcare system.

3.1.3 Risk, effectiveness, and confirmation
Risk emerged as a multifaceted concept in the interviews: conceptualizations of
risk ranged from safety concerns about new contraceptive methods, to surgical risk, to
concerns about regret, to contraception failure and pregnancy risk. Regarding new
methods of contraception, including NSPC, women’s perspectives revolved around their
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conceptualizations of risk. The majority of participants had safety and side effect
concerns about new methods, often filtered through past experience with hormonal
contraception. For example, one 23-year old participant explained:
“I think it's [development of new contraceptive methods] fantastic because you
have many choices, but sometimes those choices are not technically the greatest
ones for you or ones that you particularly like... I mean I struggled for the longest
time to find one that worked for me... I did the depo and I gained so much weight,
and it messed with my self-esteem.”
In general, women stated interest in new methods, but didn’t want to be an early adopter.
Negative media exposure, such as TV advertisements targeting IUD complications, were
cited several times as instilling skepticism and heightened sense of risk with respect to
contraceptive methods:
“I would want to hear a little bit about…how long those trials have been and how
long it’s been researched, ‘cause there’s lots of things that have been out on the
market, you know, for a good five/ten years that they’re discovering later have
some nasty side effects.”
The weighing of risks and benefits was a main theme in women’s decision-making
around PC. Risks related to PC may not be ‘worth it’ when considering the length of
anticipated benefit. One 36 year-old participant put it this way:
“Because right now I have a 3-year birth control [method] and if there was
something like a 5 or 10 year, I'd probably just get that and then wait for
menopause. Because I'm old enough where it wouldn't be 30 years. And it's such a
minor thing that I probably wouldn't bother with a surgery.”
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The risk of pregnancy, or of contraceptive failure, was another risk women prioritized.
While several respondents spoke of concern for surgical PC failure, most women
perceived surgical PC as inherently more effective than a nonsurgical procedure:
“Well, it (NSPC) sounds safer…But it kind of also sounds less effective.”
“Um, I mean, it'd be less - I assume it'd be less costly, which would be nice.
But...you know, if it's non surgical I'd also want to know, like, how are you really
able to see what you're doing and has this been tested before, on what? …and
what are the probabilities of it, you know, not working, because it's not surgical.”

When asked if it would be important to have a confirmation test done if a given method
of PC were 99% effective, the majority of our sample strongly felt that it was necessary
to come back for a confirmation test regardless of the stated efficacy of the method.
While some (9/40) said that 99% effectiveness was “good enough,” several had the
expectation that surgical PC should have a 0% failure rate:
“Yeah, I would wanna make sure everything was safe...uh...that there's no
chances at all...[of pregnancy]…Especially if it’s supposed to be permanent.”

3.2 Focus group discussion
In general, providers welcomed efforts to expand contraceptive options with
NSPC. Most commented on the challenges of providing highly effective contraception
among patient populations who are wary of hormonal methods and “foreign bodies” such
as implants and IUDs. In the same vein, once it was explained that polidocanol foam
dissipates in the body, providers felt such a method would be more acceptable to some
patients than placement of an IUD or implant. The majority of the providers felt that
avoiding surgery when possible was in everyone’s interest.
Participants emphasized the need for long-term (which they defined as 5-10
years) data on safety and efficacy of any new method, and had questions about the
specifics of a nonsurgical method’s physiology and the need to confirm tubal occlusion.
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Particularly in the absence of long-term follow up data, participants felt strongly that
confirmation of tubal occlusion would be necessary, though did point out the
inconsistency that despite knowledge of surgical PC failure, it is still not standard of care
to confirm tubal occlusion after tubal ligation. A few providers also spoke to their
observations that patients tend to perceive surgery as the most effective method, and thus
may prefer surgical PC.
Providers described the difficulties they faced in presenting new methods to
patients. One participant commented that ‘selling’ a new method “[requires] overcoming
some skepticism…and then really being able to articulate it well to patients.” Another
OB/GYN noted her experience after she began offering Essure® as an office procedure:
“At first when the concept came out [Essure®], I thought it was ridiculous when
we have so many other better methods. Why would you want to go through that?
But after doing so many cases, I think it is a very good option.”

When asked if they foresaw ethical issues with NSPC, some providers expressed concern
that the relative ease of a nonsurgical method could undermine the inherent seriousness
of choosing permanent contraception – concern “that the population could be confused
about the procedure…that they wouldn’t take it as seriously, maybe.” Two other
participants commented,
Participant 1: “My worry would be that it's so simple that those who - that there
would be a temptation to minimize the gravity of something permanent…or just
making that conversation a little too brief because if all I need to do is put this little
tube in and go [motions] and squirt, then –“
Participant 2: “Yeah, a 15 minute appointment for their permanent sterilization!”

The importance of counseling patients regarding PC was emphasized in the discussion.
Providers described counseling for surgical sterilization as “ritualized,” with multiple
steps and an expectation that each patient is extensively counseled about risks and
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alternatives. As one provider summarized, “the counseling needs to be the same [for
NSPC] as it is for surgical [PC].”

4. Discussion
This study is the first to explore perceptions of new methods of nonsurgical
permanent contraception among a sample of women and OB/GYNs in the U.S., and
contributes to the small body of literature on NSPC. Interview participants, the majority
of whom identified as future users of PC, expressed a strong interest in a nonsurgical PC
method. The concepts of risk and effectiveness framed women’s and FGD respondents’
perceptions of NSPC, as well as their responses to PC and new contraceptive methods
more generally.
Various risk perception theories have been developed to try to understand the
ways in which people judge and react to risk, with a vast attendant literature [25]. Many
health-related behaviors are studied with the lens of risk perception, such as perceived
HIV risk and sexual behavior [26]. While the risk perception literature around
contraception is relatively sparse, the concepts are widely applied: Demographic Health
Surveys globally feature women’s fears of contraceptive side effects [27,28]; a recent
cohort study found that women underestimate the effectiveness of intrauterine
contraception and overestimate health risks [29]; and many populations at risk for
unintended pregnancy are also at risk for misinformation around risks associated with
unprotected intercourse and contraceptive use [30,31]. In our study, women’s risk
perception of NSPC was shaped by past contraceptive experiences, perceptions of PC,
and how the risk of pregnancy was balanced against those of method use. It is important
to note here that women generally did not use the word “risk” except to describe surgical
and anesthesia-related risks. Many women expressed risk perceptions in the form of
concern, worry, and the weighing of benefits and harms. We did not exclude women
whose partners have undergone vasectomy, as technically they are still “at risk” for
pregnancy. We did not find any specific variant views among the three women in this
category, but it is possible that these participants may have found NSPC less relevant to
their lives, and less likely to share engaged perceptions.
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Our participants held surgical PC to a different metric than barrier or reversible
contraception—that is, they expected surgical PC to be permanent, or 100% effective.
In light of most participants’ belief that surgical PC represented the pinnacle of
contraceptive effectiveness (though no information regarding the efficacy of surgical or
nonsurgical PC was provided), many assumed a nonsurgical approach to PC would be
less effective. Thus, women, as well as providers, almost universally felt a confirmation
of tubal occlusion would be necessary. We hypothesize that some women may simply
feel more secure with a confirmation test if offered, and that the knowledge that one has
had surgery for PC affects risk perception. It is also possible that women and providers
alike are more confident when the tubes are visualized and occluded surgically, despite
known surgical sterilization failure [32]. Transcervical approaches may inspire less
assurance given that they may not be immediately effective and the interruption of the
tube cannot be seen. In the context of some participants’ choice of less effective methods
despite identifying as family complete, their concern about a potential <1% failure rate of
NSPC seemed particularly uncoupled from their present pregnancy risk perception.
NSPC is designed for high- and low-resource settings alike, but a novel, low-cost,
accurate confirmation test will be essential, as the hysterosalpingogram is not a practical
approach in many communities around the world [33].
Provider FGD participants highlighted two characteristics of NSPC that raised
their concern: the ease of performing the procedure seemed to be at odds with the
inherent seriousness—the permanence—of a permanent method. They emphasized the
need for the counseling around NSPC to reflect the seriousness and permanence of the
method—and that the informed consent procedures for NSPC will need to be as
“ritualized” as they are for surgical PC. In other words, providers felt that the counseling
process for NSPC should not be abbreviated even if the procedure were simpler, safer,
and cheaper.
Our findings must be interpreted in light of several limitations. Our sample is not
representative of women and OB/GYNs in Portland or the broader U.S. Indeed, the
majority of our sample was white and 50% had a college or graduate degree, which does
not reflect the demographics of women most likely to opt for PC nationally [34]. While
the sample size was appropriate given standards in qualitative research [35], it may have
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been beneficial to have purposively sampled women with lower educational attainment,
as well as women identifying as Asian and African-American. Also, we did not address
perceptions of immediate versus delayed efficacy of PC in detail, and this should be
explored in future research. Given the preliminary and hypothesis-generating goals of the
study, we conducted only one FGD with OB/GYNs; it is possible that additional FGDs
would have yielded varying insights. Social desirability bias is also a consideration; it is
possible that participants felt inclined to show a positive interest in NSPC given the faceto-face interaction with interviewers. Finally, we asked women to comment on their
perceptions of NSPC, which is not yet available. Though our questions were centered on
characteristics of NSPC, rather than on specifics of the method, women were still asked
to consider NSPC in the hypothetical. Women’s responses to a physically available
method may have been different [21].
NSPC, while still theoretical, has the potential to transform the safety and
accessibility of PC. In addition to the basic science, research on women’s, men’s, and
providers’ perceptions of a given method is critical to the contraceptive development
process. We found that perceptions of NSPC among both women and providers hinged
on how they weigh various risks and perceive the effectiveness of a given contraceptive
method. Future research on NSPC must include the perceptions of a more diverse group
of women, both nationally and internationally. One particular area of interest is the role
of confirmation tests of tubal occlusion, and how to balance risk of PC failure with costs,
including inconvenience. Furthermore, prior to rolling out a new nonsurgical method,
strategies for patient counseling and informed consent specific to NSPC must be
developed. Such research must incorporate hypothesis-driven research on perceptions and
preferences that will inform eventual clinical trials.

14

ACCEPTED MANUSCRIPT

Acknowledgments
The authors acknowledge the staff at the OHSU Center for Women’s Health, as well as
Virginia Garcia Memorial Health Clinic for their assistance with recruitment. We also
thank the OHSU Women’s Health Research Unit for regulatory and technical support,
and the focus group respondents for their participation and insights. This study was
supported by the Bill & Melinda Gates Foundation, Global Development Grants
OPP1060424, OPP1084270.

15

ACCEPTED MANUSCRIPT

References
[1] United Nations, Department of Economic and Social Affairs, Population Division.
World Contraceptive Use 2010 (POP/DB/CP/Rev2010). 2011; Accessed Mar 1 2013:
http://www.un.org/esa/population/publications/wcu2010/Main.html.
[2] Darroch J. Trends in contraceptive use. Contraception 2013; 87(3):259-63.
[3] Pati S, Cullins V. Female sterilization. Evidence. Obstet Gynecol Clin North Am,
2000;27(4):859-899.
[4] Mosher WD, Jones J. Use of contraception in the United States: 1982– 2008. Vital
Health Stat 2010;23:1–4.
[5] Peterson HB. Sterilization. Obstetrics & Gynecology 2008;111(1): 189-203.
[6] Bartz D, Greenberg JA. Sterilization in the United States. Reviews in Obstetrics &
Gynecology 2008;1(1): 23-32.
[7] Barry E, Raj S. 12 Women Die After Botched Government Sterilizations in India.
The New York Times. 2014 Nov 14. Accessed Dec 1 2014 at
http://www.nytimes.com/2014/11/12/world/asia/botched-government-sterilizationsindia.html
[8] Rodriguez MI, Jensen JT, Darney PD, Little SE, Caughey AB. The financial effects
of expanding postpartum contraception for new immigrants. Obstet Gynecol 2010;
120(3): 552-558.
[9] Potter JE, White K, Hopkins S, Shedlin MG, Amastae J, Grossman D. Frustrated
demand for sterilization among low-income Latinas in El Paso, Texas. Perspectives on
Sexual and Reproductive Health 2012; 44(4):228–235.
[10] Zite N, Wuellner S, Gilliam M. Barriers to obtaining a desired postpartum tubal
sterilization. Contraception 2006;73(4):404-407.

16

ACCEPTED MANUSCRIPT
[11] Thurman AR, Janecek T. One-year follow-up of women with unfulfilled postpartum
sterilization requests. Obstet Gynecol 2010; 116(5): 1071-1077.
[12] Bhatt, R. Quinacrine nonsurgical female sterilization in Baroda, India: 23 years of
follow-up of 84 women. International Journal of Gynecology and Obstetrics 2003;83
Suppl2:S31-33.
[13] Zipper J, Kessel E. Quinacrine sterilization: a retrospective. International Journal of
Gynaecology and Obstetrics 2003;83 Suppl 2:S7-11.
[14] Hieu DT. Tan TT, Tan DN, Nguyet PT, Than P, Vinh DQ. 31,781 cases of nonsurgical female sterilisation with quinacrine pellets in Vietnam. Lancet 1993; 24(342):
213-217.
[15] Sokal DC, Trujillo V, Guzman SC, Guzman-Serani R, Wheeless A, Hubacher D.
Cancer risk after sterilization with transcervical quinacrine: updated findings from a
Chilean cohort. Contraception, 2010;81(1):75-78.
[16] Sokal DC, Hieu do T, Loan ND, Hubacher D, Nanda K, Weiner DH, Vach TH.
Safety of quinacrine contraceptive pellets: results from 10-year follow-up in Vietnam.
Contraception, 2008;78(1):66-72
[17] Http://www.essure.com. Accessed 20 February 2015.
[18] Coleridge SP. Sclerotherapy and foam sclerotherapy for varicose veins. Phlebology
2008;24(6):260-9.
[19] Jensen JT. Permanent contraception: modern approaches justify a new name.
Contraception 2014;89:493–4.
[20] Jensen JT, Hanna C, Yao S, Micks E, Edelman A, Holden L, et al. Blockade of tubal
patency following transcervical administration of polidocanol foam: initial studies in
rhesus macaques. Contraception 2014;89:540–9.
[21] Heise, L. Beyond Acceptability: Reorienting research on contraceptive choice. In:
Beyond Acceptability: Users' Perspectives on Contraception. Sundari Ravindran TK,
Berer M, Cottingham J, editors. Reproductive Health Matters for the World Health
Organization; 1997.
[22] Bilgrami M, Shah L. Marie Stopes Society, Pakistan: 1000 cases of quinacrine
sterilization (QS). Int J Gynaecol Obstet 2003 Oct; 83 Suppl 2: S125-7.

17

ACCEPTED MANUSCRIPT
[23] Charmaz K. Constructing Grounded Theory: A Practical Guide for Qualitative
Analysis. Thousand Oaks, CA: Sage Publications Inc.; 2006.
[24] Strauss A, Corbin J. Basics of Qualitative Research: Techniques and Procedures for
Developing Grounded Theory. Thousand Oaks, CA: Sage; 1998.
[25] Wildavsky A, Dake K. Theories of risk perception: Who fears what and why?
Daedalus 1990;119 (4):41-60.
[26] MacKellar DA, Valleroy LA, Securaetal GM. Perceptions of lifetime risk and actual
risk for acquiring HIV among young men who have sex with men. AIDS and Behavior
2007; 11(2):263–70.
[27] Kenya National Bureau of Statistics (KNBS), and ICF Macro. Kenya Demographic
and Health Survey 2008-09. 2010; Accessed 15 January 2012.
http://dhsprogram.com/pubs/pdf/FR229/FR229.pdf
[28] Central Statistical Office (CSO), Ministry of Health (MOH), Tropical Diseases
Research Centre (TDRC), University of Zambia, and Macro International Inc. 2009.
Zambia Demographic and Health Survey 2007. Calverton, Maryland, USA: CSO and
Macro International Inc.
[29] Hladky KJ, Allsworth JE, Madden T, Secura GM, Peipert JF. Women's knowledge
about intrauterine contraception. Obstet Gynecol 2011;117:48–54.
[30] Gilliam ML, Warden M, Goldstein C, Tapia B. Concerns about contraceptive side
effects among young Latinas: a focus-group approach. Contraception 2004;70(4):299–
305.
[31] Biggs MA, Foster DG. Misunderstanding the risk of conception from unprotected
and protected sex. Women’s Health Issues 2013;23(1):e47–e53
[32] Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussel J. The risk of
pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of
Sterilization. American Journal of Obstetrics & Gynecology 1996;174(4):1161-70.
[33] Patil E, Thurmond A. The history and current status of fallopian tube pressures –
developing alternate methods for confirmation of tubal occlusion. Article in press. DOI:
http://dx.doi.org/10.1016/j.contraception.2015.01.003

18

ACCEPTED MANUSCRIPT
[34] Anderson JE, Jamieson DJ, Warner L, Kissin DM, Nangia AK, Macaluso M.
Contraceptive sterilization among married adults: national data on who chooses
vasectomy and tubal sterilization. Contraception 2012;85(6):552-7.
[35] Morse JM. Designing Funded Qualitative Research. In: Denzin NK, Lincoln YS,
editors. Handbook of Qualitative Research. Thousand Oaks, CA: Sage Publications;
1994. p. 220-235.

19

ACCEPTED MANUSCRIPT
Figure 1: Representative content from study instruments
Interview Guide: Attitudes towards sterilization & surgery
What do you think about permanent contraception? [Probe: Do you have
concerns about permanent contraception (“tubes tied” and sterilization)?
What do people in your community say about permanent contraception?
[Probe: your friends, partner, family members?]
What do you think about having a sterilization surgery (getting your “tubes tied”)
at the time of delivery?
Have you had surgery before? What kind of surgery? What do you think makes
something surgical?
Currently, permanent contraception requires a surgical procedure. Are you
comfortable with the idea of surgery for permanent contraception?
[Probe: do you have specific concerns regarding surgery? Is there anything about
surgical sterilization that is appealing to you?]
Interview Guide: Attitudes and features of new contraceptive technology
If a safe and effective method of permanent contraception could be provided
without the need for surgery, would this interest you?
[PROMPT: what specifically would interest you about such a method and why?
What questions and concerns would you have?]
How do you react when you hear about a new method of contraception being
available? [Probe: Are you interested in trying it right away? Are you
hesitant…?]
Currently, a special exam can demonstrate if a permanent contraceptive surgery
has completely blocked the tubes, but this requires a pelvic exam and an X-ray.
If a method of permanent contraception were 99% effective, would it be
important for you to come back for a confirmation test visit?
[Probe: If the method were 90% effective, would your answer differ?]
Focus Group Guide: Introductory script
“A nonsurgical method of permanent contraception is in development. The
technique would be office-based, and similar to the placement of an IUD. This
method would use a catheter similar to those used during an HSG for
transcervical delivery of a sclerosing foam. There would be no need for
specialized equipment or ultrasound. Anesthesia would not be required.”
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Table 1: Participant Characteristics
Interviews: Married/partnered women (n = 40)
No. participants (%)
Mean age (median, range)
33 (32, 23-42)
Race/ethnicity
White
27 (67%)
Latina
10 (25%)
Native American
3 (8%)
Education
High school or less
8 (20%)
Some college
12 (30%)
College degree
15 (37%)
Graduate degree
5 (13%)
Marital status
Married
28 (70%)
Unmarried
12 (30%)
Religion
Catholic
14 (35%)
Protestant
10 (25%)
Mormon
2 (5%)
Jewish
2 (5%)
Buddhist
1 (3%)
None
11 (27%)
Currently pregnant
20 (50%)
Median live children (range)
1 (0-4)
Number of children
0-1
25 (63%)
2
8 (20%)
3 or more
7 (17%)
Fertility intention
More children desired
8 (20%)
No more children desired
28 (70%)
Unsure
4 (10%)
Current FP method (n = 20)
Condoms 1, oral contraception 1, DMPA 1,
implant/IUD 8, vasectomy 3, none 5, missing
1
Focus Group: Obstetrician/Gynecologists (n = 9)
Practice type
Academic
6
Private group
2
Solo
1
Median years in practice, including 13 (mean 16, range 4-42)
residency
Sex
Female 8, Male 1
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